Tag Archives: False and Misleading

Antidepressant Drugs Are Not Safe During Pregnancy—No Matter What the Pharma Shills Say

Medical News Today published an article entitled “Increased Depression Screening Needed During Pregnancy, Study Says,” that is so highly misleading, we wonder if they ever bother checking the validity of what they’re forwarding under the guise of “medical news.” We’re going to make this really simple—the findings are bogus not to mention highly misleading and dangerous to anyone who would believe in the validity of this so-called study.

Jury took little more than three hours to decide antipsychotic drug maker sent out false & misleading information

“Under Louisiana’s Medical Assistance Program Integrity Law (MAPIL), anyone who attempted to defraud or cause false and misleading information to disseminate, you are subject to civil monetary fine,” says Morrow. According to the evidence, Janssen made some 27,000 phone sales calls to doctors and sent hundreds of “dear doctor letters” downplaying the diabetes link to Risperdal.

Johnson & Johnson to Pay $257 Million Over Antipsychotic Drug Marketing Tactics

Johnson & Johnson lost a $257.7 million jury verdict in Louisiana for making misleading claims about the safety of the company’s Risperdal antipsychotic drug.
J&J officials defrauded the state’s Medicaid system by wrongfully touting Risperdal as superior to competing antipsychotic drugs and minimizing its links to diabetes, said jurors in state court in Opelousas, Louisiana.